Tuesday, 20 Nov 2018

You are here

Nailfold Capillaroscopy Portends Prognosis in Systemic Sclerosis

Two reports underscore the importance of nailfold capillaroscopy (NFC) in scleroderma and have shown that nailfold capillary drop out was significantly associated with mortality in systemic sclerosis.

A study of 99 patients from the  South Australian Scleroderma Register (SASR) followed patients from 1991 to 2015. The cohort included 99 patients with limited cutaneous SSc, 30 patients with diffuse cutaneous SSc and 23 with an overlap scleroderma syndrome. Overall there were 56 deaths. 

Diffuse scleroderma had significantly greater capillary drop out compared with limited and overlap scleroderma (p<0.001). Both capillary drop out scores and antibody status were associated with mortality.

Another study from Brazil extensively studied 170 SSc patients with high-resolution computed tomography, pulmonary function tests, and Doppler echocardiography and NFC with an avascular score.  After a  mean of 10 years, 73 patients died. (Citation source https://buff.ly/2nIvHQW)

NFC avascular score was significantly associated with mortality (HR 1.64, p = 0.001). The NFC association with mortality was was stronger than that of race, gender, anticentromere antibodies, anti-topoisomerase I antibodies, form of disease, but had similar strength to the overall skin score in univariate analyses.

Capillary loss was associated with higher risk of death and be a useful tool in prognostic evaluation of SSc.   

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

AURA-LV Trial - Voclosporin Effective in Lupus Nephritis

The AURA-LV trial assessed voclosporin, a calcineurin inhibitor in patients with active lupus nephritis (LN) and found that low-dose voclosporin may be successfully added to mycophenolate mofetil and corticosteroids to controll active LN.

Pilot Data on Rituximab in Henoch-Schonlein Purpura

Management of Henoch-Schonlein purpura (HSP) can be challenging as supportive care and avoidance of corticosteroids are often insufficient options. A new series of case reports and literature review of steroid refractory HSP suggests that rituximab may be effective in reducing hospital admissions, overall steroid use, and is capable of inducing remission.

Scleroderma Expert Treatment Preferences

Frustration may be the word that best characterizes many scleroderma management plans - owing to a lack of trials, lack of agreement and lack of clear guidance on management.

A panel of concerned experts  on systemic sclerosis (SSc) set out to develop consensus on SSc treatment algorithms.

IgG4-Related Disease: First Draft Criteria Presented at ACR 2018

As Dr. John Stone, MD, MPH recounted in his presentation regarding the new ACR/EULAR Classification Criteria for IgG4-Related Disease (IgG4-RD), only 15 years prior, IgG4-related disease was an unknown entity in the medical community.

Update on Myositis

The ACR/ARHP 2018 national meeting in Chicago presented us with opportunities to learn more about inflammatory myositis. A particularly interesting lecture was HOT topics in myositis. There were a few abstracts on MDA-5 related disease and a few on new or repurposed medications for dermatomyositis which will be covered here.